The study carried out a calorimetric test (ITC) and docking simulation (DS) showing the activity of AChE inhibitors, which were 16 hydroxybenzoic acids, in order to select the most effective derivatives that could be safely used in the diet of people with dementia. Here, ACHE is linked to dementia.